πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 812 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10226521

Genetically modified Yersinia as vaccines against Yersinia species

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10220082

WT1 vaccine

Inovio Pharmaceuticals, Inc. Β· Granted Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10206995

Live attenuated virus vaccines for la crosse virus and other bunyaviridae

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10197577

Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10172932

Ebola virus disease vaccine taking human replication deficient adenovirus as vector

Institute of Biotechnology, Academy of Military Medical Sciences, China Β· Granted Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10172930

Virus like particle purification

Takeda Vaccines, Inc. Β· Granted Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10172933

Mosaic vaccines for serotype a foot-and-mouth disease virus

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10166288

Vaccines having an antigen and interleukin-21 as an adjuvant

Inovio Pharmaceuticals, Inc. Β· Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10167320

Purification of virus like particles

Takeda Vaccines, Inc. Β· Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10160957

Development of dengue virus vaccine components

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10137186

Compositions and methods for live, attenuated alphavirus formulations

Takeda Vaccines, Inc. Β· Granted Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10130705

Vaccines with interleukin-33 as an adjuvant

Inovio Pharmaceuticals, Inc. Β· Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10130696

Method of conferring a protective immune response to norovirus

Takeda Vaccines, Inc. Β· Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10130700

Polyvalent influenza virus-like particles (VLPS) and use as vaccines

The United States of America, as represented by the Secretary, DHHS Β· Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10111950

Modified glycolipids and methods of making and using the same

VACCINEX, INC. Β· Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10105436

Smallpox vaccine for cancer treatment

Calidi Biotherapeutics, Inc. Β· Granted Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10086061

Combination purified inactivated vaccine for flaviviruses

The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research Β· Granted Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10071150

Immunity enhancing therapeutic vaccine for HPV and related diseases

MYGT Biopharmaceutical LLC Β· Granted Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10064923

Therapeutic cancer vaccines derived from a novel dendritic cell line

DCPRIME B.V. Β· Granted Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10058602

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10046045

Vaccine compositions and uses thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10036751

Method of evaluating glioblastoma multiforme patient applicable to immunotherapy treatment

China Medical University Hospital Β· Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10035981

Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

The Regents of the University of California Β· Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10034934

Porcine epidemic diarrhea virus vaccines and methods of use thereof

Regents of the University of Minnesota Β· Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted